| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |